FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Wound Healing topics
Wound Healing
Amino Acid
Amino Acid Sequence
Proliferation
Theophylline
Inflammation
Antimicrobial
Epithelial
Amino Acids
Skin Graft
Bone Healing
Vascular Disease
Skin Ulcer
Bacterial Infection
Dysfunction

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Wound Healing patents



      
           
This page is updated frequently with new Wound Healing-related patent applications. Subscribe to the Wound Healing RSS feed to automatically get the update: related Wound RSS feeds. RSS updates for this page: Wound Healing RSS RSS


Method for obtaining sterile human amniotic fluid and uses thereof

Method for obtaining sterile human amniotic fluid and uses thereof

Date/App# patent app List of recent Wound Healing-related patents
01/22/15
20150025443
 Topical compositions to treat circulatory disorders patent thumbnailnew patent Topical compositions to treat circulatory disorders
The invention relates to transdermal compositions including nifedipine, pentoxifylline, ketamine hydrochloride, gabapentin, lidocaine, and prilocaine that may be used to treat conditions such as circulatory disorders and peripheral neuropathy. Additionally, methods of the invention are directed to treating conditions such as circulatory disorders, peripheral neuropathy, wound healing, blood flow issues, or the like, comprising the steps of transdermal or topical administration of the compositions..
Cmdp Licensing, Llc
01/22/15
20150025366
 Method for obtaining sterile human amniotic fluid and uses thereof patent thumbnailnew patent Method for obtaining sterile human amniotic fluid and uses thereof
Provided herein is a method for sterilely filtering amniotic fluid from selected caesarean sections of an individual. The amniotic fluid is first centrifuged at 5,000 to 10,000 rpm for 30 to 60 minutes and filtered through filters with about 5 to about 10 μm pore size.
01/22/15
20150025342
 Methods for measuring changes in optical properties of wound tissue and correlating near infrared absorption(fnir) and diffuse refelectance spectroscopy scattering (drs) with tissue neovascularization and collagen concetration to determine whether wound is healing patent thumbnailnew patent Methods for measuring changes in optical properties of wound tissue and correlating near infrared absorption(fnir) and diffuse refelectance spectroscopy scattering (drs) with tissue neovascularization and collagen concetration to determine whether wound is healing
Optical changes of tissue during wound healing measured by near infrared and diffuse reflectance spectroscopy are shown to correlate with histologic changes. Near infrared absorption coefficient correlated with blood vessel in-growth over time, while diffuse reflectance spectroscopy (drs) data correlated with collagen concentration.
Philadelphia Health & Education Corporationd D/b/a Drexel University College Of Medicine
01/22/15
20150025013
 Compositions and methods of use for (pro)renin receptor patent thumbnailnew patent Compositions and methods of use for (pro)renin receptor
Disclosed are methods of treating kidney disease, infectious or inflammatory diseases, acute kidney injury and hypertension by administering a (pro)renin receptor (prr) antagonist. In some instances the prr antagonist is a polypeptide.
University Of Utah
01/15/15
20150018966
 Decellularisation of tissue matrices for bladder implantation patent thumbnailDecellularisation of tissue matrices for bladder implantation
The invention provides an improved method of producing a natural, acellular matrix scaffold for subsequent use in tissue-engineered replacement of tissues such as the bladder. Decellularisation is carried out on an expanded or distended bladder and the product retains the strength and compliance of natural material.
Tissue Regenix Limited
01/15/15
20150018433
 Fluorinated polymerizable hydrogels for wound dressings and methods of making same patent thumbnailFluorinated polymerizable hydrogels for wound dressings and methods of making same
Fluorinated hydrogels are used to dissolve oxygen or other oxygenated small molecules. The fluorinated hydrogels may release the dissolved oxygen or other oxygenated small molecules upon exposure to an environment of lower tension.
The University Of Akron
01/15/15
20150018292
 Bioactive alkaloid compositions and their medical uses patent thumbnailBioactive alkaloid compositions and their medical uses
The present invention relates to a novel alkaloid and novel bioactive alkaloid fractions derivable from ribes preferably selected among ribes rubrum and ribes nigrum; methods of manufacturing such bioactive ribes alkaloid fractions and their use for the inhibition of ikk-β, pde4 and/or pde5 and in addition their promoting effect on mitochondrial biogenesis and function; their therapeutic or non-therapeutic applications as nutritive or medicinal products in the management of conditions associated with impaired mitochondrial function or ikk-β, pde4 and/or pde5 activity, such as inflammation, neurodegeneration, dyslipidemia, type 2 diabetes mellitus, impaired wound healing, sarcopenia and other conditions associated with muscle dysfunction or tiredness and fatigue, or where optimization of muscular or cognitive function is desired; extracts, juices or concentrates of ribes comprising such alkaloids; compostions comprising such alkaloids, including pharmaceutical compositions, nutritive product such as functional foods and nutraceutical compositions, and cosmetic compositions and medical devices.. .
Asiros A/s
01/15/15
20150017862
 Gelatin non-woven structures produced by a non-toxic dry solvent spinning process patent thumbnailGelatin non-woven structures produced by a non-toxic dry solvent spinning process
The gelatin non-woven can be cross-linked by heat-treatment or chemical cross-linking, and the non-woven is biocompatible as measured by fibroblast growth in vitro and wound healing on pigs in vivo.. .
01/08/15
20150011747
 Methods for making biocompatible polymerizable acrylate products patent thumbnailMethods for making biocompatible polymerizable acrylate products
Sugar-acrylic monomers are synthesized to have a carbohydrate moiety linked to an acrylate group. The sugar-acrylic monomers may be polymerized to form polymers, adhesives, hydrogels, and the like.
Empire Technology Development Llc
01/08/15
20150010610
 Immunocompatible amniotic membrane products patent thumbnailImmunocompatible amniotic membrane products
Provided herein is a placental membrane product comprising an immunocompatible amniotic membrane. Such placental membrane products can be cryopreserved and contain therapeutic factors and viable cells after thawing.
Osiris Therapeutics, Inc.
01/08/15
20150010609

Immunocompatible chorionic membrane products


Provided herein is a placental membrane product comprising an immunocompatible chorionic membrane. Such placental membrane products can be cryopreserved and contain therapeutic factors and viable cells after thawing.
Osiris Therapeutics, Inc.
01/01/15
20150004263

Composition and a wound healing


A herbal composition for wound healing is disclosed. The herbal composition comprises an extract of honeysuckle and an extract of mint in a weight ration of 1:2 to 2:1.
Han Sheng Biotech Co., Ltd.
01/01/15
20150004261

Rhizoma arisaematis extracts and uses thereof for wound-healing effects


Provided are water and alcohol extracts of rhizoma arisaematis, compounds isolated from rhizoma arisaematis (such as 3-o-(9,12-octadecadienoyl)-glyceryl-β-d-galactopyranoside, n-(β-d-ribofuranos-1-yl)-phenylalanine, and adenosine), pharmaceutical compositions comprising the aforementioned ingredients, as well as uses thereof for promoting wound healing. In one embodiment, the pharmaceutical composition is a topical formulation, such as a cream, ointment, foam, lotion, plaster, gel, and emulsion..
The Hong Kong University Of Science And Technology
12/25/14
20140377320

Selective plasma activation for medical implants and wound healing devices


A treated surface of a device (10) for implantation or for application as a wound dressing, comprises an array of plasma-activated hydrophilic cell-adhesive areas (18) having the ability to reduce fibrous reaction, is in the form of an array of islets of activation. Each islet of activation (18) has a length which is less than 6 μm, a width which is less than 2 μm and the distance between islets is preferably from 4 μm to 6 μm.
Chuv, Centre Hospitalier Universitaire Vaudois
12/25/14
20140377195

Polymer composition containing natural bioactive principles for use in pharmaceutical and cosmetic formulations


The present invention relates to a polymer composition containing natural bioactive principles, in particular propolis extract. The present composition is of value because it exhibits antimicrobial (antibacterial, antifungal, antiviral and antiprotozoal), wound healing, anti-inflammatory, antioxidising and moisturising properties.
Bioative Tecnologia Em Polimeros Ltda-me
12/18/14
20140371691

Apparatus and wound cleansing with actives


An apparatus and method for cleansing and applying therapy or prophylaxis to wounds, in which irrigant fluid, which may contain a physiologically active material, and wound exudate from the dressing are moved by a device for moving fluid through a flow path which passes through the dressing. A means for fluid cleansing may also be provided to recirculate fluid back to the dressing.
Smith & Nephew Plc
12/04/14
20140358226

Light adjustable iol with diffraction multifocal


A light adjustable diffraction multifocal intraocular lens (iol), according to the present invention, is a mutifocal iol whose optical power (prescription) may be adjusted by exposure to an energy source after implantation and subsequent wound healing. It makes use of a diffraction element to create the multifocal nature of the iol which retains its structural integrity despite exposure to the power changing energy source..
12/04/14
20140358069

Method and dermatological treatment and tissue reshaping


The present invention provides improved methods and apparatus for skin treatment and tissue remodeling. The apparatus includes an array of needles that penetrate the skin and serve as electrodes to deliver radio frequency current or other electrical or optical energy into the tissue being treated, causing thermal damage in controlled patterns.
12/04/14
20140357733

Methods relating to identification of susceptibility to liver injury


The present invention relates to methods for identifying susceptibility of impaired hepatic wound healing in a patient, most particularly by identifying modifications of the of ppar-γ and tgfβ1 genes. It further relates to stratifying populations of patients to determine susceptibility to impaired hepatic wound healing and direct appropriate healthcare resources.
12/04/14
20140357645

Advanced formulations and therapies for treating hard-to-heal wounds


A method for healing a hard-to-heal wound including the steps of: topically administering a wound healing composition to a wounded area, wherein the wound healing composition includes, at least one of: (a) a medicament characterized as a calcium channel blocker or pharmaceutically acceptable salts or solvates thereof; (b) a medicament characterized as an alpha-adrenergic antagonist or pharmaceutically acceptable salts or solvates thereof; (c) a medicament characterized as a direct vasodilator or pharmaceutically acceptable salts or solvates thereof; and (d) a medicament characterized as a phosphodiesterase type five inhibitor or pharmaceutically acceptable salts or solvates thereof; and (e) a hemorrheologic agent or pharmaceutically acceptable salts or solvates thereof; (f) a primary dermal penetrating agent or pharmaceutically acceptable salts or solvates thereof: and (g) a topical stimulating agent or pharmaceutically acceptable salts or solvates thereof.. .
12/04/14
20140357553

Nutritional composition for wound healing


A nutritional composition for promoting would healing comprises a protein source, a lipid source and a carbohydrate source wherein no more than 1.8% of the total calories of the composition derive from arginine and wherein the protein source includes praline in an amount of at least 3% of the total calories of the composition. The composition may be administered orally and is particularly suitable for the amelioration of pressure ulcers although it may also be used with advantage in the nutritional management of acute wounds including pre and post surgery..
12/04/14
20140356334

Methods for improved wound closure employing olivamine and endothelial cells


The present disclosure relates to compositions for and methods of improving wound healing, including compositions for and methods of treating chronic wounds, and compositions for the inhibition and treatment of necrosis and extended quiescence that result in cellular necrosis instead of normal proliferation. The methods for wound healing administer one or more compositions including hydroxytyrosol and oleuropein with cells derived from umbilical cord blood..
11/27/14
20140350527

"self-regulating device for modulating inflammation"


A bioreactor is provided which contains cells capable of producing cytokine inhibitors in response to cytokines, in a manner regulated by the local or systemic milieu of an individual patient and predicted by mechanistic computational simulations. The bioreactor transfers the cytokine inhibitors to a patient in need of control of the inflammation process as part of a disease or condition in the patient, such as sepsis, trauma, traumatic brain injury, or wound healing.
11/27/14
20140350021

Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases


The present methods and compositions are of use for treatment of conditions involving fibrosis, such as peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a pde-4 inhibitor, a pde-5 inhibitor, a compound that elevates cgmp and/or pkg, a stimulator of guanylyl cyclase and/or pkg, a combination of a compound that elevates cgmp, pkg or no with an antioxidant that decreases ros, or a compound that increases mmp activity..
11/27/14
20140349933

Self-assembled composite ultrasmall peptide-polymer hydrogels


The present invention relates to composite hydrogels comprising at least one non-peptidic polymer and at least one peptide having the general formula: z—(x)m—(y)n—z′p, wherein z is an n-terminal protecting group; x is, at each occurrence, independently selected from an aliphatic amino acid, an aliphatic amino acid derivative and a glycine; y is, at each occurrence, independently selected from a polar amino acid and a polar amino acid derivative; z′ is a c-terminal protecting group; m is an integer selected from 2 to 6; n is selected from 1 or 2; and p is selected from 0 or 1. The present invention further relates to methods of producing the composite hydrogels, to uses of the composite hydrogels for the delivery of drugs and other bioactive agents/moieties, as an implant or injectable agent that facilitates tissue regeneration, and as a topical agent for wound healing.
11/27/14
20140348940

Amniotic membrane hydrogel and methods of making


The present invention provides compositions and methods for wound healing and tissue regeneration. The compositions of the present invention comprise amniotic membrane of the placenta.
11/27/14
20140348775

Wound treatment drug for external use


[means for solving problem] preparation of a wound treatment drug for external use containing oily bases and iodine but substantially no white soft sugar, which is a characteristic of the drug of this invention. The invented drug prevents infection through the wound surface due to a sufficient bactericidal effect of iodine, and promotes wound healing, prevents cicatrization and reduces iodine accumulation on the wound surface by maintenance of appropriate moisture in the wound surface due to a moisturizing effect of oily bases..
11/27/14
20140348774

Method for treating wounds and tissue repair


The present inventions relate to a number of fields including wound healing, a waterless antibacterial disinfectant, a surgical scrub, insect repellant, and methods of treating traumatic injuries, particularly those on the battlefield where there is a need to stabilize the patient and prevent infection.. .
11/20/14
20140343129

Modified nucleic acids, and acute care uses thereof


The invention provides compositions and methods for effecting wound healing in a mammal, where the compositions include therapeutic mrna which incorporate modified nucleosides and nucleotides.. .
11/20/14
20140342986

Compositions and methods for treating diseases


This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, raynaud's syndrome, heparin overdose, vulvodynia, and wound healing.
11/20/14
20140342015

Amniotic membrane powder and methods of making


The present invention provides compositions and methods for wound healing and tissue regeneration. The compositions of the present invention comprise amniotic membrane of the placenta.
11/20/14
20140341865

Dressing material with cell components for wound healing


There is provided a dressing for treating a wound. The dressing for healing a wound can be useful in maintaining a moisture environment at a wound site using a biocompatible polymer scaffold, and effectively promoting healing of a wound by various growth factors secreted by skin cells or stem cells attached to the biocompatible polymer scaffold as well..
11/13/14
20140336564

System for reduced scarring of wounds


A system for reduced scarring of wounds; said system comprising: means (1) for creating an enclosed volume (3) over a wound site (2). The system further comprises: means (6, 10, 11, 12) for actively reducing the oxygen concentration within the enclosed volume at the surface of the wound to a first oxygen concentration level while maintaining an environment within the enclosed volume which is healthy for wound healing, means (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14) for ensuring that the oxygen concentration of the gas composition of the gas within the enclosed volume at the surface of the wound is maintained below a second oxygen concentration level and above a third oxygen concentration level, and where said system is arranged such that said first, second and third oxygen concentration levels are between 1 and 16 volume percent..
11/13/14
20140336557

Biopolymer multi-layer multi-functional medical dressing and making same


The technology described herein applies to medical dressings designed to heal wounds in the area of advanced wound care, inclusive of negative pressure wound therapy (npwt), and describes novel wound healing absorbent scaffolds and dressing based on natural and naturally-derived material and fibers, preferentially poly (lactic) acid fibers and alginate materials.. .
11/13/14
20140335183

Wound healing profile


The present invention relates to compositions and methods for tissue regeneration, particularly for treating skin lesions such as wounds. In one aspect, the invention provides wound healing composition characterised by the higher expression levels of phenotypic marker genes such as apolipoprotein d, matrix metalloprotease (2), collagen 3a1 and smooth muscle actin than the housekeeping gene ribosomal protein l32.
11/13/14
20140335149

Wound-healing promoting material


The object of the present invention is to provide a means for utilizing cells that have effects on wound healing as wound-healing promoting materials by efficiently concentrating such cells within a short period of time. The present invention provides a wound-healing promoting material which comprises a sheet-like porous body having on its surface at least leukocytes and/or platelets, a method for producing the same, a device for producing the same, and a method for treating wound sites using the same..
11/06/14
20140330226

Combination sis and vacuum bandage and method


A wound care bandage for treating a wound is provided. The bandage includes an sis layer to be placed on the wound surface and a cover to placed over the wound.
11/06/14
20140328902

Antimicrobials and methods of use thereof for wound healing


This disclosure provides generally for antimicrobial compositions and methods of use comprising an anthocyanin, an anthocyanidin or metabolites thereof. Methods for promoting healing of a wound using these compositions are also disclosed.
11/06/14
20140328859

Antibodies and methods for wnt pathway-related diseases


The transmembrane e3 ubiquitin ligases znrf3 and rnf43 are negative regulators of β-catenin and the wnt signaling pathway in eukaryotic cells. The activity of znrf3 can be modulated by antibody binding to its extracellular domain, thus causing an increase in wnt signaling.
11/06/14
20140328789

Ph-responsive cell scaffold and using same


A ph-responsive cell scaffold for growing a cell culture is disclosed. The cell scaffold has pores in which biological cells may be disposed.
10/30/14
20140324120

Integrated surface stimulation device for pain management and wound therapy


The present invention provides a thin and flexible device and method of use thereof for pain and wound treatment of a subject. The integrated surface stimulation device may comprise a complete wireless stimulation system in a disposable and/or reusable flexible device for widespread use in multiple therapeutic applications.
10/30/14
20140322797

Method for removing endotoxin from proteins


Disclosed is a method for removing endotoxin from proteins. Also disclosed are products made by using the method.
10/30/14
20140322368

Method of reducing and improving the appearance of scar tissue


Scars, stretch marks, keloids, keratosis, and other skin lesions can be ameliorated through topical application of a composition containing a fortified botanical complex inhibiting tryptase and chymase. A flavonoid with antioxidant properties valuable in inflammatory stress; blocking the release of histamine, inhibiting leukocytic elastase and strengthening the protective properties surrounding the extracellular matrix.
10/16/14
20140309215

4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors


Which are useful as prolyl hydroxylase inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity.
10/16/14
20140309195

Small molecules that promote skin regeneration


Provided herein are small molecules for the induction of fibroblast proliferation and increased secretion or production of proteins. The small molecules described herein can be used for the promotion of skin regeneration.
10/09/14
20140302112

Bone matrix compositions and methods


Osteoinductive compositions and implants having increased biological activities, and methods for their production, are provided. The biological activities that may be increased include, but are not limited to, bone forming; bone healing; osteoinductive activity, osteogenic activity, chondrogenic activity, wound healing activity, neurogenic activity, contraction-inducing activity, mitosis-inducing activity, differentiation-inducing activity, chemotactic activity, angiogenic or vasculogenic activity, and exocytosis or endocytosis-inducing activity.
10/02/14
20140294996

One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss


Biologically active extracts of one or more vigna marina (burm.) merr., cocos nucifera l., or terminalia catappa l, and compositions one or more of the extracts are described. The invention also provides therapeutic and cosmetic uses of the extracts and compositions, in particular for promoting wound healing and for the treatment of skin disorders..
10/02/14
20140294944

Microencapsulation of oxygen liberating reactants


There is provided a composition for the delivery of oxygen having microencapsulated peroxide and microencapsulated catalyst that liberate oxygen upon sufficient contact with each. The components may be stored separately or together until use.
10/02/14
20140294786

Alimentary protein-based scaffolds (aps) for wound healing, regenerative medicine and drug discovery


The invention provides engineered biomaterials derived from plant products. The engineered biomaterials are useful for biomedical applications.
09/18/14
20140277048

Methods and handpiece for use in tissue dissection


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140277047

Methods of tissue release to reduce the appearance of cellulite


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140277027

Cellulite treatment methods


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140277026

Device for dissection of subcutaneous tissue


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140277025

Apparatus for reducing the appearance of cellulite


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140277024

Tissue treatment system for reducing the appearance of cellulite


A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
09/18/14
20140276493

Wound healing compositions


Provided herein are biologically active solution compositions comprising one or more sacrificial proteolytic enzyme substrates, one or more preservatives, and one or more antimicrobial agents and methods of using the solution compositions to treat tissue sites, in particular chronic wounds. The compositions may be used in conjunction with negative pressure wound therapy to treat tissue sites..
09/18/14
20140276354

Biophotonic materials and uses thereof


The present disclosure provides biophotonic materials and methods useful in phototherapy. In particular, the biophotonic materials of the present disclosure include a cohesive matrix, and at least one chromophore, wherein the at least one chromophore can absorb and emit light from within the biophotonic material.
09/18/14
20140276324

Wound or skin treatment devices with variable edge geometries


Devices, kits and methods described herein are provided for treatment to skin, including but not limited to wound healing, the treatment, amelioration, and/or prevention of scars or keloids. A book-like packaging, applicator and/or tensioning device can be used to apply a dressing to a subject.
09/18/14
20140276323

Wound or skin treatment devices with variable edge geometries


Devices, kits and methods described herein are provided for treatment to skin, including but not limited to wound healing, the treatment, amelioration, and/or prevention of scars or keloids. A book-like packaging, applicator and/or tensioning device can be used to apply a dressing to a subject.
09/18/14
20140275218

Wound healing compositions and treatments


This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase..
09/18/14
20140275209

Wound healing compositions and treatments


This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase..
09/18/14
20140274872

Compositions and treatments based on cadherin modulation


Anti-cadherin and anti-zo-1 agents and compositions, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.. .
09/18/14
20140271802

Wound healing using topical systems and methods


The present invention generally relates to compositions and methods for topical or transdermal delivery and treatment of wounds and/or promoting wound healing. In some cases, the composition may include nitric oxide and/or peptides.
09/18/14
20140271732

Wound healing using topical systems and methods


The present invention generally relates to compositions and methods for topical or transdermal delivery and treatment of wounds and/or promoting wound healing. In some cases, the composition may include nitric oxide and/or peptides such as thyrotropin-releasing hormone (trh) and/or gnrh (gonadotropin-releasing hormone).
09/18/14
20140271539

Novel use of members of il-10 cytokine family


The invention relates to a novel use of the members of the il-10 cytokine family in wound healing. Particularly, the invention relates to the use of the member of the il-10 cytokine family in the promotion of the proliferation and the migration of keratinocyte cells in wound healing..
09/11/14
20140257272

Handpiece and methods for performing subcutaneous surgery


Devices and methods for performing subcutaneous surgery in a minimally invasive manner are provided. The methods include application of reduced air pressure in a recessed area of a handpiece placed over a section of skin and drawing the section of skin and subcutaneous tissue into the recessed area.
09/11/14
20140257218

Apparatus & wound infection prevention


A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous layers of the skin. The wound healing device includes a first portion that is positioned external of, and on top of, the wound.
09/11/14
20140257211

Wound cleansing apparatus with stress


An apparatus for cleansing wounds with means for stressing the wound bed and optionally tissue surrounding the wound, in which irrigant fluid from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are recirculated by a devise for moving fluid through a flow path which passes through the dressing and a means for fluid cleansing and back to the dressing. The cleansing means (which may be a single-phase, e.g.
09/11/14
20140257210

Wound management method and apparatus


A method for managing a closed incisional wound that includes at least one elastomeric drain inserted partially into the wound, an open cell foam sponge in flow communication with the drains and wound, and to which negative pressure is applied by a vacuum source. The negative pressure is transmitted into the otherwise closed wound in order to improve drainage and expedite wound healing..
09/11/14
20140256917

Compositions and methods for osteogenic gene therapy


The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth.
09/11/14
20140255961

Synthetic microfluidic systems for wound healing and hemostasis


A method of assaying wound healing can include: growing cells on the matrix in the first flow channel; introducing an agent that removes the matrix from the junction; introducing a matrix material into the second flow channel so as to form the second matrix in the second flow channel and junction; and detecting cellular migration into the junction onto the second matrix. The agent that removes the matrix can include a biomolecule or chemical agent.
09/11/14
20140255357

Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells


Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin.


Popular terms: [SEARCH]

Wound Healing topics: Wound Healing, Amino Acid, Amino Acid Sequence, Proliferation, Theophylline, Inflammation, Antimicrobial, Epithelial, Amino Acids, Skin Graft, Bone Healing, Vascular Disease, Skin Ulcer, Bacterial Infection, Dysfunction

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Wound Healing for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Wound Healing with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         





0.6632

3525

1 - 1 - 72